In vitro prednisolone resistance signature in MLL-rearranged infant ALL
收藏官方服务：
资源简介：
In vitro prednisolone resistance signature in MLL-rearranged infant ALL
应用场景：
创建时间：
2011-10-12
相关数据集
sj-xlsx-3-tct-10.1177_15330338211041464 - Supplemental material for EIF3B Associates with Exacerbated Clinical Features, Poor Treatment Response and Survival in Adult Philadelphia Chromosome Negative Acute Lymphoblastic Leukemia Patients
Supplemental material, sj-xlsx-3-tct-10.1177_15330338211041464 for EIF3B Associates with Exacerbated Clinical Features, Poor Treatment Response and Survival in Adult Philadelphia Chromosome Negative A
DataCite Commons2024-08-28 更新40
HLA specificities are associated with prognosis in IGHV-mutated CLL-like high-count monoclonal B cell lymphocytosis
IntroductionMolecular alterations leading progression of asymptomatic CLL-like high-count monoclonal B lymphocytosis (hiMBL) to chronic lymphocytic leukemia (CLL) remain poorly understood. Recently, g
Figshare2017-03-02 更新10
Asymmetric and symmetric dimethylarginines and mortality in patients with hematological malignancies—A prospective study
The study was designed to determine the associations of asymmetric (ADMA) and symmetric (SDMA) dimethylarginines plasma concentrations with all-cause mortality in patients with hematological malignanc
Figshare2018-05-22 更新10
DataSheet_1_Characteristics, Treatment Complexity, and Outcome of Mixed-Phenotype Acute Leukemia in Children in a Low–Middle-Income Country.docx
BackgroundMixed-phenotype acute leukemia (MPAL) in children is an uncommon subtype of acute leukemia that cannot be definitively assigned to a specific lineage. There is no consensus on the best appro
NIAID Data Ecosystem20
Table_2_Elevated Lactate Dehydrogenase Levels Display a Poor Prognostic Factor for Non-Hodgkin’s Lymphoma in Intensive Care Unit: An Analysis of the MIMIC-III Database Combined With External Validation.xlsx
BackgroundAmong the growing number of patients with hematologic neoplasms hospitalized in the intensive care unit (ICU), the largest proportion of these patients are diagnosed with lymphoma. However,
NIAID Data Ecosystem10
